CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 133 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,648,000 | -34.5% | 789,603 | -45.4% | 0.35% | -47.0% |
| Q1 2020 | $5,571,000 | +452.7% | 1,446,953 | +632.3% | 0.66% | +362.9% |
| Q1 2019 | $1,008,000 | +191.3% | 197,594 | +9.7% | 0.14% | +107.2% |
| Q4 2018 | $346,000 | -54.8% | 180,198 | -11.0% | 0.07% | -57.1% |
| Q3 2018 | $765,000 | +63.5% | 202,489 | +35.0% | 0.16% | -14.4% |
| Q2 2018 | $468,000 | +56.0% | 150,000 | +49.8% | 0.19% | +9.9% |
| Q3 2015 | $300,000 | -84.6% | 100,129 | -74.7% | 0.17% | -82.9% |
| Q2 2015 | $1,951,000 | +23.5% | 395,000 | +8.2% | 1.00% | +22.6% |
| Q1 2015 | $1,580,000 | +68.8% | 365,000 | +15.9% | 0.82% | +136.9% |
| Q4 2014 | $936,000 | – | 315,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |